Vir Biotechnology Names Jason O’Byrne CFO
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
- Latest
- Trending
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
L&T Semiconductor and IBM collaborate to design advanced processors, boosting L&T shares. Focus on automotive, energy, and more.
AMD's CEO declares the dawn of an AI supercycle with new high-powered chips, aiming to challenge Nvidia's dominance.
Goldman Sachs expert discusses how Fed rate cuts, elections, and AI influence the tech sector's future.
Dow drops 410 points as August jobs report disappoints and tech shares slide, impacting market sentiment and investor confidence.
Ethereum drops below $2,300 after US jobs data. JP Morgan analyzes ETF performance with Bitcoin comparison.
Klarna eyes US share sale before IPO, valued at $20B, backed by Sequoia and Softbank.
Explore Broadcom's Q3 earnings report and its potential influence on the semiconductor industry.
UBS downgrades long-term USD targets, recommends fading any strength due to expected structural weakness into 2025.
Render cryptocurrency experiences a 3.56% drop in price, reducing its market cap to $1.89 billion over the past 24 hours.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.